Addressing the U.S. Opioid Crisis
Addressing the U.S. Opioid Crisis
In 2017, the U.S. Department of Health and Human Services declared a nationwide public health emergency regarding the opioid crisis.1 Each day, according to the Centers for Disease Control and Prevention (CDC), it is estimated that more than 140 Americans die from drug overdoses, 91 specifically due to opioids.2
West Virginia is one of the states hardest hit by the opioid epidemic. According to the CDC, West Virginia has the highest overdose death rate in the United States,3 with opioids responsible for most overdose deaths in the state.4 The state also ranks first nationally for rates of hepatitis B and second for rates of hepatitis C.5 The growing opioid epidemic may lead to a rise in the number of people contracting other infectious diseases such as HIV and hepatitis C.6
Our Response to the Opioid Epidemic in West Virginia
To help address the opioid crisis in West Virginia, our company’s Foundation is supporting a new initiative with Marshall Health through a $2 million grant spread over four years (2018-2021) to establish the Great Rivers Regional System for Addiction Care (the System). This comprehensive, integrated program will respond to the opioid crisis in the Great Rivers Region of West Virginia. It also will help develop a model for others working to tackle the challenges of the opioid epidemic and the spread of infectious diseases associated with the epidemic.
The Great Rivers Regional System for Addiction Care
The System will serve as a hub that coordinates the efforts of all program partners to help reduce opioid addiction, improve access to substance abuse prevention and treatment services, and help reduce the rising rates of HIV and hepatitis C infections.
The System includes comprehensive public health harm-reduction programs; quick response teams (featuring a medical provider, a law enforcement officer, and a treatment-and-recovery provider) that visit individuals following an overdose incident; care centers that connect individuals with addiction to recovery resources and treatment services; and community engagement and substance abuse prevention education.
Given the substantial need to combat the opioid epidemic in West Virginia, the Great Rivers Regional System for Addiction Care has four overarching goals:
- Reduce opioid overdoses and overdose deaths;
- Increase access to and retention in substance abuse treatment;
- Enhance access to care for viral hepatitis and HIV; and
- Improve public health education to increase awareness and prevention of substance abuse and addiction.
An independent evaluator will assess the impact and outcomes of the System, and help Marshall Health and its program partners identify the most effective community-based programs to combat the opioid crisis. This assessment will aid in creating a potential model that can be adapted by local health care and public health systems in other states or regions to improve their own responses to this public health crisis.
|1. Department of Health and Human Services. “Determination That a Public Health Emergency Exists.” https://www.hhs.gov/sites/default/files/opioid%20PHE%20Declaration-no-sig.pdf accessed July 2018.|
2. Department of Health and Human Services. “HHS Acting Secretary Declares Public Health Emergency to Address National Opioid Crisis.” https://www.hhs.gov/about/news/2017/10/26/hhs-acting-secretary-declares-public-health-emergency-address-national-opioid-crisis.html accessed July 2018.
3. Centers for Disease Control and Prevention. “Drug Overdose Data.” https://www.cdc.gov/drugoverdose/data/statedeaths.html accessed July 2018.
4. Centers for Disease Control and Prevention. “Increases in Drug and Opioid Overdose Deaths—United States, 2000–2014.” https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6450a3.htm accessed July 2018.
5. Centers for Disease Control and Prevention. “Surveillance for Viral Hepatitis—United States, 2016.” https://www.cdc.gov/hepatitis/statistics/2016surveillance/index.htm accessed July 2018.
6. Centers for Disease Control and Prevention. “Increases in Hepatitis C Virus Infection Related to Injection Drug Use Among Persons Aged ≤30 Years — Kentucky, Tennessee, Virginia, and West Virginia, 2006–2012 Weekly.” https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6417a2.htm?s_cid=mm6417a2_w accessed July 2018.